RD&C combines diverse academic and scientific background with broad expertise and long experience in pharmaceutical industry and offers a highly specified and exceptional portfolio to its clients.

Drug discovery and development process – from target validation to clinical phase


Stability, impurities and degradation products – from identification to justification


Regulatory documentation – IND, DMF, QOS, CTD, ERA


Regulatory advice – deficiency letters, expert statement, regulatory strategies


Environmental Risk Assessments – a new approach to prepare ERAs


In silico toxicology assessment – from impurity profiling to ERA


Commercial evaluation of drug development projects – from idea to market


Quality Management Support – from control to audit


Audits – GMP and supplier audits


Support for CRO selection – from request to match


Statistics – an inevitable tool in drug development


IP management – from claims to product portfolio


RD&C network – from academia to industry


Publication & scientific talks – RD&C’s scientific activities